IFNG and neoplasm: Therefore, dysfunction of the HLA-I antigen processing pathway (HLA-I APP) or the IFNγ response pathway in tumor cells has been identified as a frequent cause of both primary and acquired resistance to ICIs, often correlating with worse prognosis (11–13).